113 related articles for article (PubMed ID: 20961382)
1. The plaque inhibitory effect of a CPC mouthrinse in a 3-day plaque accumulation model - a cross-over study.
Versteeg PA; Rosema NA; Hoenderdos NL; Slot DE; Van der Weijden GA
Int J Dent Hyg; 2010 Nov; 8(4):269-75. PubMed ID: 20961382
[TBL] [Abstract][Full Text] [Related]
2. The effect of toothbrushing regimens on the plaque inhibitory properties of an experimental cetylpyridinium chloride mouthrinse.
Witt J; Bsoul S; He T; Gibb R; Dunavent J; Hamilton A
J Clin Periodontol; 2006 Oct; 33(10):737-42. PubMed ID: 16899026
[TBL] [Abstract][Full Text] [Related]
3. Clinical investigation of the efficacy of a commercial mouthrinse containing 0.05% cetylpyridinium chloride in preventing dental plaque.
Lotufo R; Calil CM; Feng HS; Sekiguchi RT; Stewart B; DeVizio W; Proskin HM
J Clin Dent; 2009; 20(2):50-4. PubMed ID: 19591337
[TBL] [Abstract][Full Text] [Related]
4. Clinical investigation of the efficacy of a commercial mouthrinse containing 0.05% cetylpyridinium chloride in reducing dental plaque.
Hernandez-Cott PL; Elias Boneta A; Stewart B; DeVizio W; Proskin HM
J Clin Dent; 2009; 20(2):39-44. PubMed ID: 19591335
[TBL] [Abstract][Full Text] [Related]
5. A clinical investigation of the efficacy of a commercial mouthrinse containing 0.05% cetylpyridinium chloride to control established dental plaque and gingivitis.
Silva MF; dos Santos NB; Stewart B; DeVizio W; Proskin HM
J Clin Dent; 2009; 20(2):55-61. PubMed ID: 19591338
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the antiplaque efficacy of two cetylpyridinium chloride-containing mouthwashes.
Barnes VM; Arvanitidou E; Szewczyk G; Richter R; DeVizio W; Cronin M; Michelle S
J Clin Dent; 2011; 22(6):200-3. PubMed ID: 22403976
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial and antiplaque effects of a novel, alcohol-free oral rinse with cetylpyridinium chloride.
Witt J; Ramji N; Gibb R; Dunavent J; Flood J; Barnes J
J Contemp Dent Pract; 2005 Feb; 6(1):1-9. PubMed ID: 15719071
[TBL] [Abstract][Full Text] [Related]
8. A 6-month clinical trial to study the effects of a cetylpyridinium chloride mouthrinse on gingivitis and plaque.
Mankodi S; Bauroth K; Witt JJ; Bsoul S; He T; Gibb R; Dunavent J; Hamilton A
Am J Dent; 2005 Jul; 18 Spec No():9A-14A. PubMed ID: 16178130
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a 0.15% benzydamine hydrochloride and 0.05% cetylpyridinium chloride mouth rinse on 4-day de novo plaque formation.
Herrera D; Santos S; Ferrús J; Barbieri G; Trombelli L; Sanz M
J Clin Periodontol; 2005 Jun; 32(6):595-603. PubMed ID: 15882217
[TBL] [Abstract][Full Text] [Related]
10. Superiority of an essential oil mouthrinse when compared with a 0.05% cetylpyridinium chloride containing mouthrinse: a six-month study.
Sharma NC; Araujo MW; Wu MM; Qaqish J; Charles CH
Int Dent J; 2010 Jun; 60(3):175-80. PubMed ID: 20684443
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind clinical study to assess the antimicrobial effects of a cetylpyridinium chloride mouth rinse on dental plaque bacteria.
Hu D; Li X; Sreenivasan PK; DeVizio W
Clin Ther; 2009 Nov; 31(11):2540-8. PubMed ID: 20109998
[TBL] [Abstract][Full Text] [Related]
12. Plaque inhibition of two commercially available chlorhexidine mouthrinses.
Van Strydonck DA; Timmerman MF; van der Velden U; van der Weijden GA
J Clin Periodontol; 2005 Mar; 32(3):305-9. PubMed ID: 15766375
[TBL] [Abstract][Full Text] [Related]
13. A clinical study to assess the 12-hour antimicrobial effects of cetylpyridinium chloride mouthwashes on supragingival plaque bacteria.
He S; Wei Y; Fan X; Hu D; Sreenivasan PK
J Clin Dent; 2011; 22(6):195-9. PubMed ID: 22403975
[TBL] [Abstract][Full Text] [Related]
14. An alcohol-free therapeutic mouthrinse with cetylpyridinium chloride (CPC)--the latest advance in preventive care: Crest Pro-Health Rinse.
White DJ
Am J Dent; 2005 Jul; 18 Spec No():3A-8A. PubMed ID: 16178129
[No Abstract] [Full Text] [Related]
15. Comparison of the effects of cetylpyridinium chloride with an essential oil mouth rinse on dental plaque and gingivitis - a six-month randomized controlled clinical trial.
Albert-Kiszely A; Pjetursson BE; Salvi GE; Witt J; Hamilton A; Persson GR; Lang NP
J Clin Periodontol; 2007 Aug; 34(8):658-67. PubMed ID: 17635245
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a high bioavailable cetylpyridinium chloride mouthrinse over a 24-hour period: a plaque imaging study.
Kozak KM; Gibb R; Dunavent J; White DJ
Am J Dent; 2005 Jul; 18 Spec No():18A-23A. PubMed ID: 16178132
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of de novo plaque growth by a new 0.03 % chlorhexidine mouth rinse formulation applying a non-brushing model: a randomized, double blind clinical trial.
Mor-Reinoso C; Pascual A; Nart J; Quirynen M
Clin Oral Investig; 2016 Sep; 20(7):1459-67. PubMed ID: 26475499
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of two alcohol-free cetylpyridinium chloride mouthwashes - a randomized double-blind crossover study.
Rawlinson A; Pollington S; Walsh TF; Lamb DJ; Marlow I; Haywood J; Wright P
J Clin Periodontol; 2008 Mar; 35(3):230-5. PubMed ID: 18190554
[TBL] [Abstract][Full Text] [Related]
19. A comparison of chlorhexidine, cetylpyridinium chloride, triclosan, and C31G mouthrinse products for plaque inhibition.
Renton-Harper P; Addy M; Moran J; Doherty FM; Newcombe RG
J Periodontol; 1996 May; 67(5):486-9. PubMed ID: 8724706
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a new mouth rinse formulation based on 0.07% cetylpyridinium chloride in the control of plaque and gingivitis: a 6-month randomized clinical trial.
Costa X; Laguna E; Herrera D; Serrano J; Alonso B; Sanz M
J Clin Periodontol; 2013 Nov; 40(11):1007-15. PubMed ID: 24024983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
